...
机译:胰腺癌中化学化的分子与细胞机制
Metabolic Signalling Group School of Biomedical Sciences Curtin Health Innovation Research;
Platelet Research Laboratory Curtin Health Innovation and Research Institute Faculty of Health;
Metabolic Signalling Group School of Biomedical Sciences Curtin Health Innovation Research;
Metabolic Signalling Group School of Biomedical Sciences Curtin Health Innovation Research;
Platelet Research Laboratory Curtin Health Innovation and Research Institute Faculty of Health;
Platelet Research Laboratory Curtin Health Innovation and Research Institute Faculty of Health;
Metabolic Signalling Group School of Biomedical Sciences Curtin Health Innovation Research;
Pancreatic cancer; Chemoresistance; Gemcitabine; Tumour microenvironment;
机译:胰腺癌中化学化的分子与细胞机制
机译:吉西他滨:胰腺癌的代谢及其作用,敏感性和化学抗性的分子机制
机译:微小分子在胰腺癌化学耐药中作用的分子机制
机译:卵巢癌化学的分子决定因素:新的谜语洞察力
机译:乳腺癌化学抗性的分子机制。
机译:胰腺癌和肥胖:细胞转化和化学抗性的分子机制。
机译:胰腺癌和肥胖:细胞转化和化学性分子机制
机译:跨越种族的前列腺癌进展的分子决定因素。项目a - 人类5RD5a2基因和前列腺癌进展。项目B - 雄激素受体(aR)在前列腺癌进展中的信号传导。项目C - 前列腺癌进展核心的细胞和分子标记 - 流行病学核心